, CSO, PEPSICO, CEO Global Nutrition Group; David Kirchhoff, President, Weight Watchers; Daniel Kraft, Physician, Stanford Institute for Stem Cell Biology; Freda Lewis-Hall, CMO, Pfizer Medical; Charles Limb, Assoc. Professor, Johns Hopkins School of Medicine; Jonathan Mann, Singer, Comedian; Eric Mead, Magician, Author; Yoav Medan, VP/ Chief Systems Architect, InSightec; Catherine Mohr, Director of Medical Research, Intuitive Surgical; Farzad Mostashari, National Coordinator for Health IT, U.S. Department of Health and Human Services; Quyen Nguyen, Director, Facial Nerve Clinic, University of California San Diego; Sheila Nirenberg, Weill Medical College of Cornell University; Diana Nyad, Author, Ultra-Marathon Swimmer; Tim O'Reilly, Founder & CEO, O'Reilly Media; Todd Park, CTO, U.S. Dept. of Health and Human Services; Cheryl Pegus, CMO, Walgreen Co.; Charles Pell, Co-Founder Physcient; Michael Rosenblatt, CMO, Merck; Eric Schadt, Director, Institute of Genomics and Multiscale Biology; Jill Sobule, Singer & Songwriter; Rick Smolan, Co-Founder, Against All Odds; Paul Stamets, Founder, Fungi Perfecti Laboratories; Lee Stein, Prize Capital & Virtual Group; Chris Toumazou, Institute of Biomedical Engineering, Imperial College of London; Alexander Tsiaras, Founder & CEO The Visual MD; Loudon Wainwright III, Singer-Songwriter, Actor; Steve Wozniak, Co-Founder of Apple and Chief Scientist of Fusion-IO ; and John Wynn, Swedish Cancer Institute of Seattle.
TEDMED SponsorsThe TEDMED conference and mission are generously supported by more than a dozen major U.S. sponsors including some of the world's best-known companies. TEDMED sponsors include important thought leaders in the realm of health and medicine: The California Endowment, GE, IOMEDIA, Jawbone, Johnson & Johnson, The Robert Wood Johnson Foundation, Mars Inc., Nurture, Panasonic, PEPSICO, Qualcomm and Walgreens.
TEDMED ContributorsAbbott, Fulbright & Jawarski, LPage: 1 2 3 4 5 6 Related medicine technology :1
. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients2
. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights3
. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent4
. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month5
. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign6
. SuperGens Novel Hypomethylating Agent Highlighted at AACR Plenary Session7
. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting8
. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting9
. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing10
. Mitchell, Military TBI Task Force Highlight the Importance of Traumatic Brain Injury Research; Mitchell Endorses Ground Breaking Traumatic Brain Injury Study11
. Research Highlights Potential Benefits of Telemedicine in Treating Eye Disease